Bath & Body Works, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bath & Body Works, Inc. on June 27, 2024. The filing reports on corporate governance actions taken on the same date, specifically amendments to the Company's Bylaws and the results of the Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Corporate Actions
- Bylaw Amendments: The Board amended the Bylaws to update stockholder notice periods for proposals (now 90-120 days prior to the anniversary of the preceding year's meeting), align with SEC "universal proxy" rules (Rule 14a-19), and conform to the Delaware General Corporation Law.
- Proxy Card Requirement: Stockholders soliciting proxies must now use a proxy card color other than white.
- 2025 Meeting Deadlines: For the 2025 Annual Meeting, written notice for proposals or director nominations must be received between February 27, 2025, and March 29, 2025.
Voting Results and Management Commentary
The Annual Meeting was held on June 27, 2024, with 204,486,481 shares present or represented by proxy. Key outcomes include:
- Election of Directors: All ten nominees were elected. Notable voting statistics include:
- Stephen D. Steinour: Received the highest number of "Against" votes (9,594,180) and "Abstain" votes (166,812).
- Sarah E. Nash: Received 8,708,083 "Against" votes.
- Danielle M. Lee: Received 6,882,510 "Against" votes.
- Ratification of Auditors: Ernst & Young LLP was ratified with 198,790,248 votes for, 5,515,850 against, and 180,383 abstentions.
- Executive Compensation: The advisory vote on executive compensation passed with 96.05% of voting shares in favor (185,770,557 for, 7,632,595 against).
Investor Verification Checklist
- Verify the specific text of the Amended and Restated Bylaws (Exhibit 3.1) to confirm the exact procedural requirements for future stockholder proposals.
- Review the 2024 Proxy Statement (filed May 15, 2024) for detailed biographies of directors and the rationale behind the compensation package approved by 96.05% of voters.
- Monitor future filings for any dissenting shareholder actions related to the directors receiving significant "Against" votes (Steinour, Nash, Lee).
- Confirm the timeline for the 2025 Annual Meeting to ensure compliance with the new February 27 to March 29, 2025, notice window.